isophane human insulin

DRUG7 trials

Sponsors

Novo Nordisk A/S

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Healthy

Phase 1

Bioequivalence of Two Insulatard® Formulations in Healthy Subjects

CompletedNCT01486901

Novo Nordisk A/SDiabetes, Healthy

Start: 2006-05-31End: 2006-07-31Updated: 2015-04-28

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec

CompletedNCT01865279

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Start: 2005-12-31End: 2006-04-30Updated: 2015-10-23

Phase 4

Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes

CompletedNCT01467141

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 2002-06-19End: 2003-10-15Updated: 2017-02-23

Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes

CompletedNCT01720303

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2002-09-19End: 2003-04-10Updated: 2017-02-20

Unknown Phase

Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

CompletedNCT00410033

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 1989-12-31End: 2006-05-31Updated: 2016-12-22

Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During Real-life Usage in Germany

CompletedNCT00665808

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2007-10-31End: 2008-12-31Updated: 2016-10-28

NovoLet® Surveillance Study on Using Human Insulin System in Indonesia

CompletedNCT01492153

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Start: 2003-02-11End: 2006-09-05Updated: 2017-02-28

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01